Intellia Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

NTLA
Intellia Therapeutics

Last Price:

$11.82

Seasonality Move:

-9.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Intellia Therapeutics Stock Forecast

Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 42.3% based on the past 9 years of stock performance.
Intellia Therapeutics has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Is Intellia Therapeutics Stock Undervalued?

The current Intellia Therapeutics [NTLA] share price is $11.83. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Intellia Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 42.3% based on the past 9 years of stock performance.

Intellia Therapeutics Stock Rating

Sell

Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics overpriced?

Intellia Therapeutics has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Intellia Therapeutics Stock Price History

Is NTLA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

intelliatx.com

52-Week Data

52-Week High:

27.77

52-Week Low:

5.90

Prediction Charts

Market Cap:

1.2B

Price in USD:

11.83

Volume:

2.8M

Beta:

2.04

Technical Analysis

SMA50:

9.24

SMA100:

8.93

SMA200:

11.56

52-Wk Change:

-56.76%

Stock Predictions

Is Intellia Therapeutics stock public?

Yes, Intellia Therapeutics is a publicly traded company.
What is the Intellia Therapeutics stock quote today?

The Intellia Therapeutics stock price is 11.83 USD today.
How to buy Intellia Therapeutics stock online?

You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jun-27	9.70	9.56	10.14	9.51
Jun-30	9.56	9.38	9.68	9.33
Jul-1	9.23	9.88	10.13	8.98
Jul-2	9.95	10.73	11.08	9.89
Jul-3	10.80	10.74	10.90	10.45
Jul-7	10.65	10.25	10.83	10.18
Jul-8	10.33	11.12	11.47	10.32
Jul-9	11.50	12.13	12.25	11.40
Jul-10	12.31	12.16	12.34	11.79
Jul-11	12.01	11.54	12.13	11.27
Jul-14	11.37	11.95	12.12	11.36
Jul-15	12.17	11.48	12.20	11.31
Jul-16	11.65	11.96	12.24	11.60
Jul-17	12.12	11.83	12.40	11.80

Intellia Therapeutics Earnings

Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intellia Therapeutics Forecast Revenue Growth

Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.13 per share, and an increase next year of $0.30 per share.

* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.